Earlier clinical studies suggest that high levels of autoantibodies targeting the p45 and p210 amino acid sequences on apoB100 peptides in oxidized LDL have a protective role in the development of cardiovascular disease [7]. The gene discussed is APOB; the disease is cardiovascular disorder.